Cargando…
Treatment with Creatine Monohydrate in Spinal and Bulbar Muscular Atrophy: Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial
BACKGROUND: Although spinal and bulbar muscular atrophy (SBMA) has been classified as a motor neuron disease, several reports have indicated the primary involvement of skeletal muscle in the pathogenesis of this devastating disease. Recent studies reported decreased intramuscular creatine levels in...
Autores principales: | Hijikata, Yasuhiro, Katsuno, Masahisa, Suzuki, Keisuke, Hashizume, Atsushi, Araki, Amane, Yamada, Shinichiro, Inagaki, Tomonori, Ito, Daisuke, Hirakawa, Akihiro, Kinoshita, Fumie, Gosho, Masahiko, Sobue, Gen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859194/ https://www.ncbi.nlm.nih.gov/pubmed/29506970 http://dx.doi.org/10.2196/resprot.8655 |
Ejemplares similares
-
Impaired muscle uptake of creatine in spinal and bulbar muscular atrophy
por: Hijikata, Yasuhiro, et al.
Publicado: (2016) -
Mexiletine in spinal and bulbar muscular atrophy: a randomized controlled trial
por: Yamada, Shinichiro, et al.
Publicado: (2022) -
Quantitative Assessment of Swallowing Dysfunction in Patients with Spinal and Bulbar Muscular Atrophy
por: Hashizume, Atsushi, et al.
Publicado: (2017) -
Development of a functional composite for the evaluation of spinal and bulbar muscular atrophy
por: Inagaki, Tomonori, et al.
Publicado: (2022) -
Swallowing markers in spinal and bulbar muscular atrophy
por: Banno, Haruhiko, et al.
Publicado: (2017)